Targeting the IGF-Axis in Cultured Pediatric High-Grade Glioma Cells Inhibits Cell Cycle Progression and Survival
Pediatric high-grade gliomas (pHGG) accounts for approximately 8-12% of primary brain tumors in children. Prognosis is poor, with a median survival of 9-15 months. Insulin-like growth factor 1-receptor (IGF-1R) gene amplifications have been identified in high-grade gliomas and may contribute to its...
Saved in:
Main Authors: | Yinhsuan Michely Chen (Author), Matthew Leibovitch (Author), Michele Zeinieh (Author), Nada Jabado (Author), Pnina Brodt (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dendritic cell vaccines for high-grade gliomas
by: Eagles ME, et al.
Published: (2018) -
Research Progress About Glioma Stem Cells in the Immune Microenvironment of Glioma
by: Xiangyu Li, et al.
Published: (2021) -
ITGA1 Promotes Glioma Cell Proliferation and Affects Immune Cell Infiltration in Low-Grade Glioma
by: Yanhong Ren, et al.
Published: (2024) -
Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival
by: Peng-Fei Wang, et al.
Published: (2018) -
APELA Expression in Glioma, and Its Association with Patient Survival and Tumor Grade
by: Debolina Ganguly, et al.
Published: (2019)